CASP3 and astrocytoma (excluding glioblastoma): Furthermore, nPLA-mediated 'protection' was also observed in human astrocytoma cells (CRL-1718TM) exposed to staurosporine (STS) where increased cell viability and reduction in caspase 3 activity was observed upon nPLA treatment (Figure 3a &3b).